Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Abstract 6962: Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer

Cancer Res (2024) 84 (6_Supplement): 6962.

https://doi.org/10.1158/1538-7445.AM2024-6962

Published: 22 March 2024

View article titled, Abstract 6962: Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer

Journal Articles

Abstract 2754: Uncovering the role of TEADs in treatment induced small cell or neuroendocrine prostate cancer

Lisha G. Brown, Ilsa M. Coleman, Tony L. Chu, Daniel W. Lin, John K. Lee, Erolcan Sayar, Lawrence D. True, Ruth Dumpit, Eva Corey, Peter S. Nelson, Michael C. Haffner, Colm Morrissey

Cancer Res (2024) 84 (6_Supplement): 2754.

https://doi.org/10.1158/1538-7445.AM2024-2754

Published: 22 March 2024

View article titled, Abstract 2754: Uncovering the role of TEADs in treatment induced small cell or neuroendocrine prostate cancer

Journal Articles

Abstract PR005: Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3’ untranslated region mutations

Samantha L. Schuster, Sonali Arora, Cynthia L. Wladyka, Lukas Corey, Bethany L. Stackhouse, Lori Kollath, Eva Corey, Lawrence D. True, Dave Young, Patrick J. Paddison, Andrew C. Hsieh

Cancer Res (2023) 83 (11_Supplement): PR005.

https://doi.org/10.1158/1538-7445.PRCA2023-PR005

Published: 02 June 2023

View article titled, Abstract PR005: Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3’ untranslated region mutations

Journal Articles

Abstract B050: Human interpretation of 3D histopathology image datasets of whole prostate biopsies reveals more cribriform pattern (Gleason pattern 4) carcinoma than is seen in standard 2D histology images

Lawrence D. True, Peter A. Humphrey, Vanessa Roybal, Suet-Ling Sarah Chow, Weisi Xie, Jonathan T. C. Liu

Cancer Res (2023) 83 (11_Supplement): B050.

https://doi.org/10.1158/1538-7445.PRCA2023-B050

Published: 02 June 2023

View article titled, Abstract B050: Human interpretation of 3D histopathology image datasets of whole prostate biopsies reveals more cribriform pattern (Gleason pattern 4) carcinoma than is seen in standard 2D histology images

Journal Articles

Abstract 6617: Gleason score 6 often coexists with Gleason score 7 adenocarcinoma within 3D z-levels of a prostate biopsy

Xavier Farré, Vanessa Roybal, Can Koyuncu, Sarah Chow, Hongyi Huang, Alan Aberdeen, Andrew Janowczyk, Anant Madabhushi, Lawrence D. True, Jonathan T. Liu

Cancer Res (2023) 83 (7_Supplement): 6617.

https://doi.org/10.1158/1538-7445.AM2023-6617

Published: 04 April 2023

View article titled, Abstract 6617: Gleason score 6 often coexists with Gleason score 7 adenocarcinoma within 3D z-levels of a prostate biopsy

Journal Articles

Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning–Assisted Gland Analysis

Cancer Res (2022) 82 (2): 334–345.

https://doi.org/10.1158/0008-5472.CAN-21-2843

Published: 15 January 2022

View article titled, Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning–Assisted Gland Analysis

Includes: Multimedia, Supplementary data

Journal Articles

RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer

Mark P. Labrecque, Lisha G. Brown, Ilsa M. Coleman, Bryce Lakely, Nicholas J. Brady, John K. Lee, Holly M. Nguyen, Dapei Li, Brian Hanratty, Michael C. Haffner, David S. Rickman, Lawrence D. True, Daniel W. Lin, Hung-Ming Lam, Joshi J. Alumkal, Eva Corey, Peter S. Nelson, Colm Morrissey

Cancer Res (2021) 81 (18): 4736–4750.

https://doi.org/10.1158/0008-5472.CAN-21-0307

Published: 15 September 2021

View article titled, RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer

Includes: Supplementary data

Journal Articles

Abstract 4392: Pre-mRNA splicing factors promote cellular plasticity in castration-resistant prostate cancer

Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown, Bryce Lakely, Lori Kollath, Daniel W. Lin, Lawrence D. True, Eva Corey, Peter S. Nelson, Colm Morrissey

Cancer Res (2019) 79 (13_Supplement): 4392.

https://doi.org/10.1158/1538-7445.AM2019-4392

Published: 01 July 2019

View article titled, Abstract 4392: Pre-mRNA splicing factors promote cellular plasticity in castration-resistant prostate cancer

Journal Articles

Abstract IA21: AR is ablated: Now what? Targeting the double-negative phenotype

Cancer Res (2018) 78 (16_Supplement): IA21.

https://doi.org/10.1158/1538-7445.PRCA2017-IA21

Published: 14 August 2018

View article titled, Abstract IA21: AR is ablated: Now what? Targeting the double-negative phenotype

Journal Articles

Abstract 1092: Defining the molecular phenotypes of metastatic castration-resistant prostate cancer sensitive to FGF pathway inhibition

Mark P. Labrecque, Lisha G. Brown, Ilsa M. Coleman, Lawrence D. True, Lori Kollath, Bryce Lakely, Yu C. Yang, Holly M. Nguyen, Eva Corey, Peter S. Nelson, Colm Morrissey

Cancer Res (2018) 78 (13_Supplement): 1092.

https://doi.org/10.1158/1538-7445.AM2018-1092

Published: 01 July 2018

View article titled, Abstract 1092: Defining the molecular phenotypes of metastatic castration-resistant prostate cancer sensitive to FGF pathway inhibition

Journal Articles

Abstract 1718: The importance of clinically relevant rapid autopsy specimens and LuCaP patient-derived xenograft models to interrogate the heterogeneous and evolving treatment resistance of castration-resistant prostate cancer

Colm Morrissey, Ming H. Lam, Tia S. Higano, Lawrence D. True, Martine Roudier, Robert B. Montgomery, Peter S. Nelson, Paul H. Lange, Evan Y. Yu, Robert L. Vessella, Eva Corey

Cancer Res (2015) 75 (15_Supplement): 1718.

https://doi.org/10.1158/1538-7445.AM2015-1718

Published: 01 August 2015

View article titled, Abstract 1718: The importance of clinically relevant rapid autopsy specimens and LuCaP patient-derived xenograft models to interrogate the heterogeneous and evolving treatment resistance of castration-resistant prostate cancer

Journal Articles

Abstract 406: Characterizing the molecular features of the neuroendocrine phenotype in castration resistant prostate cancer.

Xiaotun Zhang, Ilsa Coleman, Roger Coleman, Khanhthy Doan, Martine Roudier, Lisly Chéry, Jennifer Noteboom, Celestia Higano, Lawrence D. True, Paul H. Lange, Peter S. Nelson, Robert L. Vessella, Colm Morrissey

Cancer Res (2013) 73 (8_Supplement): 406.

https://doi.org/10.1158/1538-7445.AM2013-406

Published: 15 April 2013

View article titled, Abstract 406: Characterizing the molecular features of the neuroendocrine phenotype in castration resistant prostate cancer.

Journal Articles

Abstract 5122: Characterizing the molecular features of ERG positive tumors in primary and castration resistant prostate cancer.

Martine Roudier, Ilsa Coleman, Xiaotun Zhang, Roger Coleman, Lisly Chéry, Lisha Brown, Bryce Lakely, Celestia Higano, Lawrence D. True, Paul H. Lange, Shiv Srivistava, Aykut Üren, Eva Corey, Robert L. Vessella, Peter S. Nelson, Colm Morrissey

Cancer Res (2013) 73 (8_Supplement): 5122.

https://doi.org/10.1158/1538-7445.AM2013-5122

Published: 15 April 2013

View article titled, Abstract 5122: Characterizing the molecular features of ERG positive tumors in primary and castration resistant prostate cancer.

Journal Articles

Abstract 5059: Exome and targeted sequencing to discover and validate candidate genes in advanced and lethal prostate cancer

Akash Kumar, Alexandra P. MacKenzie, Brian J. O'Roak, Ilsa Coleman, Colm Morrissey, Choli Lee, Thomas A. White, Ruth F. Dumpit, Lawrence D. True, Eva Corey, Robert L. Vessella, Peter S. Nelson, Jay Shendure

Cancer Res (2012) 72 (8_Supplement): 5059.

https://doi.org/10.1158/1538-7445.AM2012-5059

Published: 15 April 2012

View article titled, Abstract 5059: Exome and targeted sequencing to discover and validate candidate genes in advanced and lethal prostate cancer

Journal Articles

Abstract 5249: LuCaP prostate cancer xenografts: Models that allow clinically relevant investigation of prostate cancer in a preclinical setting

Holly M. Nguyen, Colm M. Morrissey, Peter S. Nelson, Xiaotun Zhang, Stephen R. Plymate, Celestia S. Higano, Paul H. Lange, Lawrence D. True, Martine PM Roudier, Robert L. Vessella, Eva Corey

Cancer Res (2012) 72 (8_Supplement): 5249.

https://doi.org/10.1158/1538-7445.AM2012-5249

Published: 15 April 2012

View article titled, Abstract 5249: LuCaP prostate cancer xenografts: Models that allow clinically relevant investigation of prostate cancer in a preclinical setting

Journal Articles

Abstract 1532: The identification of osteoblastic and osteolytic factors in prostate cancer bone metastases

Xiaotun Zhang, Sandy Larson, Ruth Dumpit, Ilsa Coleman, Bryce Lakely, Martine Roudier, Celestia Higano, Lawrence D. True, Paul H. Lange, Peter S. Nelson, Eva Corey, Robert L. Vessella, Colm Morrissey

Cancer Res (2012) 72 (8_Supplement): 1532.

https://doi.org/10.1158/1538-7445.AM2012-1532

Published: 15 April 2012

View article titled, Abstract 1532: The identification of osteoblastic and osteolytic factors in prostate cancer bone metastases

Journal Articles

Abstract 1583: The biological and molecular characterization of 24 unique prostate cancer xenograft lines, including responses to therapy

Holly M. Nguyen, Eva Corey, Colm Morrissey, Peter S. Nelson, Xiaotun Zhang, Stephen R. Plymate, Celestia S. Higano, Paul H. Lange, Martine P. Roudier, Lawrence D. True, Robert L. Vessella

Cancer Res (2011) 71 (8_Supplement): 1583.

https://doi.org/10.1158/1538-7445.AM2011-1583

Published: 15 April 2011

View article titled, Abstract 1583: The biological and molecular characterization of 24 unique prostate cancer xenograft lines, including responses to therapy

Journal Articles

Variability in the Androgen Response of Prostate Epithelium to 5α-Reductase Inhibition: Implications for Prostate Cancer Chemoprevention

Elahe A. Mostaghel, Linda Geng, Ilona Holcomb, Ilsa M. Coleman, Jared Lucas, Lawrence D. True, Peter S. Nelson

Cancer Res (2010) 70 (4): 1286–1295.

https://doi.org/10.1158/0008-5472.CAN-09-2509

Published: 14 February 2010

View article titled, Variability in the Androgen Response of Prostate Epithelium to 5α-Reductase Inhibition: Implications for Prostate Cancer Chemoprevention

Includes: Supplementary data

Journal Articles

Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer

Ilona N. Holcomb, Janet M. Young, Ilsa M. Coleman, Keyan Salari, Douglas I. Grove, Li Hsu, Lawrence D. True, Martine P. Roudier, Colm M. Morrissey, Celestia S. Higano, Peter S. Nelson, Robert L. Vessella, Barbara J. Trask

Cancer Res (2009) 69 (19): 7793–7802.

https://doi.org/10.1158/0008-5472.CAN-08-3810

Published: 01 October 2009

View article titled, Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer

Includes: Supplementary data

Journal Articles

Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease

Dolores Di Vizio, Jayoung Kim, Martin H. Hager, Matteo Morello, Wei Yang, Christopher J. Lafargue, Lawrence D. True, Mark A. Rubin, Rosalyn M. Adam, Rameen Beroukhim, Francesca Demichelis, Michael R. Freeman

Cancer Res (2009) 69 (13): 5601–5609.

https://doi.org/10.1158/0008-5472.CAN-08-3860

Published: 01 July 2009

View article titled, Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease

Includes: Multimedia, Supplementary data

NARROW

Abstract 6962: Shed Trop2 drives prostate cancer progression and Trop2 is a novel tissue prognostic biomarker and a candidate urinary marker for prostate cancer

Abstract 2754: Uncovering the role of TEADs in treatment induced small cell or neuroendocrine prostate cancer

Abstract PR005: Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3’ untranslated region mutations

Abstract B050: Human interpretation of 3D histopathology image datasets of whole prostate biopsies reveals more cribriform pattern (Gleason pattern 4) carcinoma than is seen in standard 2D histology images

Abstract 6617: Gleason score 6 often coexists with Gleason score 7 adenocarcinoma within 3D z-levels of a prostate biopsy

Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning–Assisted Gland Analysis

RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer

Abstract 4392: Pre-mRNA splicing factors promote cellular plasticity in castration-resistant prostate cancer

Abstract IA21: AR is ablated: Now what? Targeting the double-negative phenotype

Abstract 1092: Defining the molecular phenotypes of metastatic castration-resistant prostate cancer sensitive to FGF pathway inhibition

Abstract 1718: The importance of clinically relevant rapid autopsy specimens and LuCaP patient-derived xenograft models to interrogate the heterogeneous and evolving treatment resistance of castration-resistant prostate cancer

Abstract 406: Characterizing the molecular features of the neuroendocrine phenotype in castration resistant prostate cancer.

Abstract 5122: Characterizing the molecular features of ERG positive tumors in primary and castration resistant prostate cancer.

Abstract 5059: Exome and targeted sequencing to discover and validate candidate genes in advanced and lethal prostate cancer

Abstract 5249: LuCaP prostate cancer xenografts: Models that allow clinically relevant investigation of prostate cancer in a preclinical setting

Abstract 1532: The identification of osteoblastic and osteolytic factors in prostate cancer bone metastases

Abstract 1583: The biological and molecular characterization of 24 unique prostate cancer xenograft lines, including responses to therapy

Variability in the Androgen Response of Prostate Epithelium to 5α-Reductase Inhibition: Implications for Prostate Cancer Chemoprevention

Comparative Analyses of Chromosome Alterations in Soft-Tissue Metastases within and across Patients with Castration-Resistant Prostate Cancer

Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only